Today: 7 February 2026
Subscribe

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

SPCE’s October Volatility: Surge and Selloff In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech. For example, on Oct. 16 alone the stock jumped about 6% intraday. Trading volume exploded as speculative traders piled in on hopes of new catalysts ts2.tech reuters.com. However, this enthusiasm was met by profit-taking almost immediately: by Oct. 17 the stock plunged 7.9%, erasing much of the gains and closing around $4.08 ts2.tech reuters.com. The volatile swings were driven by Virgin’s history
18 October 2025
·
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Price and Performance As of mid-October 2025, Sellas Life Sciences (NASDAQ:SLS) trades around $2.10–2.20. This is near the top of its 52-week range ($0.77 low) and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume and volatility have picked up – for instance, on Oct. 14 a massive spike in call-option activity (761% above average) coincided with bullish sentiment marketbeat.com. The stock’s YTD gain (~100%) far outpaces many small-cap biotechs. Technical platforms note SLS is in “uptrend” territory: the stock is well above its 20-day EMA ($1.89) and 50-day EMA ($1.81) tipranks.com, which TipRanks flags
18 October 2025
··
Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad Zulfikar Rakhmat asiatimes.com. In practice, Jakarta is “quietly demonstrating that strategic autonomy is possible” – fielding the latest jets from East and West while balancing great-power pressures asiatimes.com. For now, Southeast Asian neighbors and global arms makers will be watching closely how this deal unfolds and how it reshapes the region’s airpower balance. Sources: Official statements and budget documents; reporting
18 October 2025
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics, a clinical-stage biotech developing the RaniPill® capsule for oral delivery of biologic drugs, was essentially flat around $0.45–$0.50 from mid-September through early October. On Oct. 17, it announced a collaboration with Chugai (which is majority-owned by Roche reuters.com) to turn one of Chugai’s injectable rare-disease antibodies into a pill formulation. The news, coupled with the new funding, ignited a buying frenzy ts2.tech. By mid-day Friday, RANI was up ~180% on the session ts2.tech, markedly outpacing the broader market’s modest gains (the S&P 500 and Nasdaq Composite were each up only ~0.5% that day investing.com). Deal Details: Under the Chugai
18 October 2025
·
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Debt Restructure Sparks Stock Crash Beyond Meat’s brand remains visible to consumers, but behind the scenes its finances are in crisis. In mid-October 2025 the company announced an early settlement of its convertible debt exchange offer, triggering a historic market reaction. As Reuters reports, BYND shareholders are “agonizing” after the company offered existing bondholders new debt and stock in place of their $1.1 billion 2027 notes reuters.com globenewswire.com. With ~96.9% of noteholders participating, Beyond Meat will issue about $196.2 M in new 7.0% convertible notes (due 2030) plus a $12.5 M tender premium – roughly $208.7 M total – and 316.15 million new shares
18 October 2025
Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Stock Surges on Q3 Results Liberty Energy’s logo (shown above) has been in the spotlight as the stock rallied on the latest earnings. On October 17, one day after Liberty’s Q3 report, the stock soared ~28% intraday, closing at $15.32 (vs. $11.94 the previous day) reuters.com ts2.tech. That move (adding about $3.4 per share of value overnight) came even though broader markets were relatively calm. Traders piled in on the “better-than-feared” outcome. By contrast, LBRT’s shares had been drifting lower for months; at one point earlier in Oct they were down over 40% on the year ts2.tech. Why the sudden
18 October 2025
··
BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

Key Facts – October 18, 2025 Stock Performance: SLS on a Tear in 2025 SELLAS Life Sciences’ stock has been on a remarkable run this year. Shares have effectively doubled in 2025, and the momentum accelerated in mid-October. On Friday Oct. 17, SLS closed at $2.14, up roughly 100% year-to-datefinbold.com. In fact, during that day’s session the stock touched a 52-week high of $2.27 (more than 3× its 52-week low of $0.77)marketbeat.com. Trading activity exploded as well – volume spiked to several times the usual level (over 6.7 million shares vs ~2.2M average) amid a flurry of speculative buying. Options
18 October 2025
Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

In summary, Gilead’s share price has rallied on a wave of HIV-related breakthroughs, pipeline achievements, and upbeat guidance. With third-quarter results due Oct. 30, investors will be watching for sustained growth. For now, analysts remain generally optimistic: the consensus rating is “Buy” (with average target ~$125) based on Gilead’s diversified portfolio and innovation investing.com ts2.tech. As management shifts into high gear on oncology and global health programs (e.g. a PEPFAR-backed plan to deliver Yeztugo overseas), the long-term outlook is that Gilead’s multiple drivers will more than offset sector risks. Sources: Recent financial filings and earnings commentary gilead.com stockanalysis.com; industry news
18 October 2025
Virgin Galactic Rockets 15% on Space Tourism Buzz – Can SPCE Defy Gravity or Crash Back to Earth?

Virgin Galactic’s Wild October Ride: SPCE Stock Soars on Space Tourism Hype, Then Plummets – What’s Next?

Key Facts – October 18, 2025 SPCE Stock Surge and Pullback After languishing near multi-year lows, Virgin Galactic’s stock staged a sharp rally in the first half of October 2025 – only to whipsaw investors with a sudden reversal. The initial catalyst was a flurry of positive news (detailed below) that sent speculative traders rushing in. SPCE climbed over 40% in two weeks, from about $3.42 on Oct. 1 to $4.89 by Oct. 16ts2.tech. On Oct. 16 alone, the stock jumped ~6%, reflecting renewed optimism. This burst of space-tourism hype lifted SPCE off its recent lows (though it remained well under early
18 October 2025
··
Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Key Facts – October 18, 2025 Stock Nosedives into Penny Territory Just a few years ago, Beyond Meat (NASDAQ: BYND) was a Wall Street darling; now it’s a penny stock cautionary tale. The company’s shares cratered below $1 this week after an early debt-restructuring announcement spooked the market. On Monday (Oct. 13), BYND opened around $0.84 – down nearly 60% from its prior close – following news of a drastic debt-for-equity swap ts2.tech. By mid-week, the stock hit record lows in the $0.50–$0.60 range, and it closed Friday at roughly $0.65 Businessinsider. This marks an astonishing fall from its 2019
18 October 2025
·
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

Key Facts – October 18, 2025 A Micro-Cap Reinvents Itself for the AI Boom New Era Energy & Digital – until recently known as New Era Helium, Inc. – has radically reinvented its business in 2025. The Midland, Texas-based company pivoted from helium and natural gas exploration toward becoming a developer of “energy-enabled” digital infrastructure for the AI erats2.tech. In August, it officially rebranded to reflect this shift, retaining its gas assets but refocusing on powering data centers. The strategic bet: build a vertically integrated campus where on-site power generation and computing facilities come together to serve the booming demand
18 October 2025
····
ATAI Life Sciences Skyrockets on FDA Breakthrough and $130M Cash Infusion

ATAI Life Sciences Skyrockets on FDA Breakthrough and $130M Cash Infusion

Key Facts – October 18, 2025 Stock Soars on Breakthrough News and Funding Boost ATAI’s stock price surged in the last few days amid a flurry of good news. Shares jumped 17.7% on Friday (Oct 17) alone, finishing at $6.45marketbeat.com, after trading around the mid-$5 range earlier in the week. In fact, as of early Friday, ATAI was already up about 8% for the week on anticipation of the announcementsnasdaq.com. The strong finish came as investors digested multiple catalysts: a coveted FDA designation for a key drug, a fresh capital raise, and bullish commentary from analysts. Notably, after-hours trading on
18 October 2025
·
Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold prices have soared this October, breaching $4,300/oz for the first time ever and up over 60% year-to-date reuters.com reuters.com. The safe-haven rally is driven by Fed rate-cut expectations, US political uncertainty and global tensions economictimes.indiatimes.com reuters.com. Analysts note no clear end to the rally: Metals Focus’s Matthew Piggott targets ~$5,000/oz absent a “major shift” ts2.tech, and HSBC now sees gold averaging near $5,000 by 2026 reuters.com reuters.com. In Asia, Diwali/Dhanteras festival buying has pushed Indian premiums to decade highs reuters.com, with domestic prices at ~₹1,31,700 per 10g reuters.com. Bullion flows are “insatiable” – record ETF inflows (~$64bn YTD) and
18 October 2025
·
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Soars 15% to 52-Week High on Psychedelic Breakthrough – What’s Next for MNMD?

Key Facts – October 18, 2025 MNMD Stock Rallies to New Highs on Heavy Volume MindMed’s stock has been on fire, vastly outperforming the broader market in recent weeks. Shares rocketed to a 52-week high of $13.09 on October 14, closing that day at $12.58 on unusually heavy volumets2.tech. After a brief mid-week pullback on profit-taking (shares dipped ~4% intraday on Oct. 16)ts2.tech, MNMD roared back by week’s end – closing at $13.65 on Friday, Oct. 17, a one-day gain of +14.6%investing.com. This rally has propelled MindMed to roughly +68% YTD returnsts2.tech, a remarkable run fueled by excitement over the
18 October 2025
·
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Key Facts – October 18, 2025 GILD Stock Price Rallies to New Heights Gilead’s stock has been on a tear in recent weeks, far outpacing the broader market. After trading in the high $110s earlier in October, GILD spiked 4.2% on Friday, Oct. 17, to close at $122.81stockanalysis.comstockanalysis.com. That rally marked a new 2025 high for the biotech stalwart and brings its year-to-date gain to roughly 45–47%ts2.tech. By comparison, the Nasdaq Biotechnology Index is up only in the single digits over the same periodts2.tech. The recent jump – adding billions to Gilead’s market cap – reflects mounting investor enthusiasm driven
18 October 2025
···
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy (LBRT) Stock Soars 28% on Earnings Surprise – Can the Rally Last?

Key Facts – October 18, 2025 Stock Skyrockets on Earnings News Liberty Energy’s latest earnings release sparked a stunning rally in its stock. On October 17, the day after results, LBRT jumped over 20% intraday, hitting the mid-$15 rangets2.tech. It ultimately closed at $15.32 on Friday (Oct 17), up 28.3% in one dayreuters.com – an eye-catching move on a day when broader markets were relatively quiet. The stock had closed at $11.94 the previous dayreuters.com, so investors added roughly $3.4 per share of value overnight in response to the news. This burst of buying follows a prolonged slump. Liberty’s stock
18 October 2025
··
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Key Facts – October 18, 2025 RANI Stock Price Explodes on Deal News Rani Therapeutics’ stock price erupted on Friday, Oct. 17, 2025, after the company unveiled its game-changing pharma partnership and a significant financing boost. In pre-market trading, RANI shares jumped over +150%, and the rally continued after the opening bellts2.techts2.tech. The stock — which had closed at just $0.47 the day before — briefly hit about $1.37 intraday (nearly a 3× gain) on extremely heavy volumets2.techts2.tech. By midday, RANI was still trading around $1.30, up ~180% on the day, marking a stunning one-day surge that lifted the stock
18 October 2025
··
AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

Tech Titans Chase the Holy Grail of AGI For decades, achieving artificial general intelligence – machines with human-level cognitive abilities across any task – has been the holy grail of AI research. In 2023, the stunning leap of OpenAI’s ChatGPT and GPT-4 brought that distant dream much closer to mainstream plausibility. Now in late 2025, the world’s largest tech companies are locked in an “unprecedented” arms race, spending hundreds of billions to be the first to cross the AGI finish line ts2.tech. Together, firms like OpenAI (with backer Microsoft), Google (through DeepMind), Meta, Anthropic, Amazon and more plan to invest
18 October 2025
·
Oil Prices Rollercoaster: Trade War Fears & OPEC Moves Spark 5-Month Lows

Oil Plunges to 5-Year Low, Gas Prices Near $3 – Are More Drops Ahead?

Key Facts – October 18, 2025 Oil Nosedives on Glut Fears and Slowdown Worries Crude oil prices have been in freefall this month, ending the week at levels not seen in nearly half a decade. The most actively traded WTI futures sank to about $57 per barrel, a price last witnessed when markets were recovering from the 2020 Covid crashmarketscreener.com. This marks a stunning reversal from early 2022, when post-pandemic demand and geopolitical shocks drove oil above $100. Now, oversupply and recession fears have firmly taken the wheel. Energy analysts point to a cascade of bearish factors. On the supply
18 October 2025
···
Gold Shatters Records Above $4,300 – Is $5,000 Next or a Pullback Coming?

Gold Shatters Records Above $4,300 – Is $5,000 Next or a Pullback Coming?

Key Facts – October 18, 2025 Gold Hits Historic Highs in October Gold’s price explosion in 2025 reached a climax this week. On Thursday, October 16, spot gold soared past $4,300/oz for the first time ever Reuters. By early Friday, it had spiked to an intraday record of about $4,378.69. This historic rally has been rapid – gold entered the year around $2,800 and has since nearly doubled, repeatedly smashing records in recent days. As of October 18, 2025, gold is hovering near $4,210/oz, cooling slightly after its meteoric rise Reuters. The late-week pullback came after a comment from U.S.
18 October 2025
1 … 1,435 1,436 1,437 1,438 1,439 … 1,633

Stock Market Today

Energy stocks set for a geopolitical week after Iran warning and oil rebound

Energy stocks set for a geopolitical week after Iran warning and oil rebound

7 February 2026
U.S. energy stocks rose Friday, with the S&P 500 energy sector up 1.88% and Exxon Mobil gaining 2.03%. Brent crude settled at $68.05 a barrel after Iran threatened U.S. bases if attacked. Saudi Aramco cut March Arab Light crude prices to a five-year low for Asia. Kazakhstan’s CPC Blend exports may drop 35% this month due to Tengiz oilfield disruptions.
Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
Go toTop